Protein kinase C: a family of isoenzymes with distinct roles in pathogenesis

Studies in this laboratory are supported by the BBSRC (JP) and the Leukaemia Research Fund. JML is a Royal Society University Research Fellow.

Levitzki A. Signal-transduction therapy. A novel approach to disease management. Eur Jt Biochem 1994;226: 1-13.

Sandier RS, Lyles CM, Peipins LA, McAuliffe CA, Woosley JT, Kupper LL. Diet and risk of colorectal adenomas: macronutrients, cholesterol and fibre. J Natl Cancer Inst 1993;85:884-91.

Inoue M, Kishimoto A, Takai Y, Nishizuka Y. Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissue. II. Proenzyme and its activation by calcium-dependent proteases from rat brain. J Biol Chem 1977;252:7610-16.

Berridge MJ. Inositol trisphosphate and diacylglycerol as second messengers. Biochem J 1984;220:345-60.

Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumour-promoting phorbol esters. J Biol Chem 1982;257:7847-5 1.

Bankey P, Carlson A, Ortiz M, Singh R, Cerra F. Tumor necrosis factor production by Kupffer cells requires protein kinase C activation. J Surg Res 1990;49:256-61.

Lord JM, Ashcroft SJH. Identification and characterization of Ca'+-phospholipid-dependent protein kinase in rat islets and hamster 1-cells. Biochem J 1984;219:547-51.

Lord JM, Johnson GD, Owen PJ. PKC-6 associates with vimentin in differentiated HL-60 cells. _7 Cell Biochem 1994;18:86.

Disatnik MH, Buraggi G, Mochly-Rosen D. Localization of protein kinase C isoenzymes in cardiac myocytes. Exp Cell Res 1994;210:287-97.

Berry N, Nishizuka Y Protein kinase C and T cell activation. Eur Biochem 1990;189:205-14. _J

Karin M. Signal transduction from cell surface to nucleus in development and disease. FASEB 1992;6:2581-90.

Clemens MJ, Trayner I, Menaya J. The role of protein kinase C isoenzymes in the regulation of cell proliferation and differentiation. Cell Sci 1992;103:881-7.

LotemJ, Sachs L. Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor 1 and cancer chemotherapy compounds in myeloid leukemic cells. Blood 1992;80: 1750-7.

The role of protein kinase C in myeloid cell apoptosis. Biochem Soc Trans 1994;22:593-7.

Parker PJ, Kour G, Marais RM, Mitchell F, Pears C, Schaap D, et al. Protein kinase C-a family affair. Mol Cell Endocrinol 1989;65: 1-11.

Dekker LV, Parker PJ. Protein kinase C-a question of specificity. Trends Biochem Sci 1994;19:73-7.

Nishizuka Y. Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992; 258:607-14.

Hug H, Sarre TF. Protein kinase C isoenzymes: divergence in signal transduction? Biochem 1993;291:329-43.

Nakanishi H, Brewer KA, Exton JH. Activation of zeta isoenzyme of protein kinase C by phosphatidylinositol 3, 4,5-trisphosphate. Biol Chem 1993;268:13-16.

Singh SS, Chauhan A, Brockerhoff H, Chauhan VPS. Activation of protein kinase C by phosphatidylinositol 3,4, 5-trisphosphate. Biochem Biophys Res Commun 1993;195: 104-12.

Gschwendt M, Kielbassa K, Kittstein W, Marks F. PKC substrates: differential phosphorylation by PKC isoenzymes [abstract]. Cell Biochem 1994;18:83D.

Asaoka Y, Nakamura S, Yoshida K, Nishizuka Y. Protein kinase C, calcium and phospholipid degradation. Trends Biochem Sci 1992;17:414-17.

Kochs G, Hummel R, Fiebich B, Sarre TF, Marme D, Hug H. Activation of purified human protein kinase C alpha and and bepthaos1phiastoiednyzlyinmoessitinolvitr4o,5b-ybiCsap2h"o,spphhoastpea.tidByiloicnhoesmitJofl 1993;291:627-33.

Murti KG, Kaur K, Goorha RM. Protein kinase C associates with intermediate filaments and stress fibers. Exp Cell Res 1992;202:36-44.

Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 1984; 308:693-8.

IB. 28 Weinstein The role of protein kinase C in growth control and the concept of carcinogenesis as a progressive disorder in signal transduction. In: Nishizuka Y, et al, eds. The biology and medicine ofsignal transduction. New York: Raven Press, 1990:307-16.

Garattini S. Pharmacology of second messengers: A critical appraisal. Drug Metabol Rev 1992;24:185-94.

Pongracz J, Clark P, NeoptolemosJP, Lord JM. Expression of proteinkinase C isoenzymes in colorectal cancer tissue and their differential activation by different bile acids.Int Cancer 1995; in press.

Levy MF, Pocsidio J, Guillem JG, Forde K, LoGerfo P, Weinstein B. Decreased levels of proteinkinase C enzyme activity and proteinkinase C mRNA in primary colon tumors. Dis Colon Rectum 1993;36:913-21.

Craven PA, Pfanstiel J, DeRubertis FR. Role of activation of protein kinase C in the stimulation of the colonic epithelial proliferation and reactive oxygen formation by Y bile acids. Clin Invest 1987;79:532-41.

O'Brian CA, Vogel VG, Singletary SE, Ward NE, Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue. Cancer Res 1989; 49:3215-17.

S, 34 Hirai M, Gamou Kobayashi M, Shimizu N. Lung cancer cells often express high levels of proteinkinase C activity. Jpn Cancer Res 1989;80:204-8.

Protein kinase C down-regulation, and not transient activation, correlates with melanocyte growth. Cancer Res 1991;51:3281-8.

S, 36 Blobe GC, Sachs CW, Khan WA, Fabbro D, Stabel Wetsel WC, et al. Selective regulation of expression of proteinkinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells-functional significance of enhanced expression of PKC-alpha. Biol Chem 1993;268:658-64.

Westmacott D, Bradshaw D, Kumar MKH, Lewis EJ, al. Murray EJ, Nixon JS, et Molecular basis of new apthera-p proachies to0 the y of rheumatoid arthritis. MolAspects Med 1991;12:395-473.

Garland LG. Is there a biochemical lesion in intrinsic asthma? Agents Actions 1989;Suppl 28:135-45.

Meurs H, Kauffman HF, Koeter GH, Timmermans A, De Vries K. Regulation of the beta-receptor adenylate cyclase system in lymphocytes of allergic patients with asthma: Possible role for protein kinase C in allergen-induced nonspecific refractoriness of adenylate cyclase. Allergy Clin Immunol 1987;80:326-39.

Kurihara H, Murayama Y, Warbington Ml, Champagne CME, Vandyke TE. Calcium dependent protein kinase C activity of neutrophils in localized juvenile periodontitis. Infect Immun 1993;61:3137-42.

Nabel G, Baltimore D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 1987;326:711-13.

Kinter AL, Poli G, Maury W, Folks TM, Fauci AS. Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells. J Virol 1990;64: 4306-12.

Boneh A, Bach G. Inhibition of protein kinase C activity in mucolipidosis type 4-a model for a new pathogenetic mechanism in inborn-errors of metabolism. Biochem Biophys Acta 1993;1182:64-8.

Bertrand F, Hermelin B, Paul A, Garcia I, Capeau E, Cherqui E, et al. Further evidence for abnormal protein kinase C regulation of macromolecule secretion in fibroblasts from cystic fibrosis patients. Biosci Rep 1990;10: 562-72.

Clarke EA, Leach KL, Trojanowski JQ, Lee VM. Characterisation and differential distribution of the three major human protein kinase C isozymes (PKC alpha, PKC beta and PKC gamma) of the central nervous system in normal and Alzheimer's disease brains. Lab Invest 1991;64:35-44.

Shimohama S, Narita M, Matsushima H, Kimura J, Kameyama M, Hagiwara M, et al. Assessment of protein kinase C isozymes by two-site immunoassay in human brains and changes in Alzheimer's disease. Neurology 1994; 43:1407-13.

Zhang W, Sakai N, Fu T, Okano Y, Hirayama H, Takenaka K, et al. Diacylglycerol formation and DNA synthesis in endothelin-stimulated rate C6 glioma cells: The possible role ofphosphatidylcholine breakdown. NeurosciLett 1991; 123:164-6.

Battini F, Leggio A, Govoni S, Frattola L, Appolonio I, Ferrarese C, et al. Decrease in phorbol ester receptors in human brain tumors. Eur Neurol 1990;30:241-6.

JAm Soc Nephrol 1994;5:611.

Gu X, Bishop SP. Increased proteinkinase C and isoenzyme redistribution in pressure-overload cardiac hypertrophy in the rat. Circulation Res 1994;75:926-31.

Crumine RC, Dubyak G, LaManna JC. Decreased protein kinase C activity during cerebral ischaemia and after reperfusion in the adult rat. J Neurochem 1990;55:2001-7.

Koizumi H, Kohno Y, Osada S, Ohno S, Ohkawara A, Kuroki T. Differentiation-associated localization of nPKCG, a Ca2"-independent proteinkinase C in normal human skin and skin diseases. JInvest Dernatol 1993;101: 853-63.

Fisher GJ, Tavakkol A, Leach K, Bums D, Basta P, Loomis C, et al. Differential expression of protein kinase C isoenzymes in normal psoriatic adult human skin-reduced expression of protein kinase C beta-II in psoriasis. J Invest Dermatol 1993;101:553-9.

Tang EY, Parker PJ, Beattie J, Housley MD. Diabetes induces selective alterations in the expression of protein kinase C isoforms in hepatocytes. FEBS Lett 1993;326: 117-23.

Inoguchi T, Battan R, Handler E, King GL. Persistent activation of protein kinase C isoform beta-II by diabetes in heart and aorta, and its differential reversibility by islet cell transplantation. Clin Res 1992;40: 141.

Herbert JM. Protein kinase C: a key factor in the regulation of tumor cell adhesion to the endothelium. Biochem Pharmacol 1993;45:527-37.

Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell 1994;78:539-42.

Trittton TR, Hickman JA. How to kill cancer cells: Membranes and cell signalling as targets in cancer chemotherapy. Cancer Cells 1990;2:95-105.

Gescher A. Towards selective pharmacological modulation of protein kinase C-opportunities for the development of novel antineoplastic agents. Brj Cancer 1992;66:10-19.

Horn F, Marks F, Fisher FJ, Marcelo CL, Voorhees JJ. Decreased protein kinase C activity in psoriatic versus normal epidermis. J Invest Dermatol 1987;88:220-2.

Chakravarty R, Rong X, Rice RH. Phorbol ester-stimulated phosphorylation of keratinocyte transglutaminase in the membrane anchorage region. Biochem J 1990;271:25-30.

Takahashi M, Tezuka T, Towatari T, Katunuma N. Identification of hematoxylin-stainable protein in epidermal keratohyalin granules as phosphorylated cystatin proteinkinase C. FEBSLett 1991;287:178-80. alpha by

Bradshaw D, Hill CH, NixonJS, Wilkinson SE. Therapeutic potential of protein kinase C inhibitors. Agents Actions 1993;38:135-47.

Cirone M, Angeloni A, Barile G, Zompetta C, Venanzoni M, Torrisi MR, et al. Epstein-Barr virus internalization and infectivity are blocked by selective protein kinase C inhibitors.Int J Cancer 1990;45:490-3.

Constantinescu SN, Cernescu CD, Popescu LM. Effects of proteinkinase C inhibitors FEBSLet 1991;292:31-3. on viral entry and infectivity.

Ryves WJ, Evans AT, Oliver AR, Parker PJ, Evans FJ. Activation of the PKC isotypoesa,P1, -6y, and t by phorbol esters of different biological activities. FEBS Lett 1991; 288:5-9.

Lord JM, Garrone B, Griffiths G, Watters D. Apoptosis induced by Bistratene A in HL60 cells involves the selective activation of PKC-5 and its association with nuclear lamins and DNA replication sites. J Cell Biochem 1995; in press.

Stanwell C, Gescher A, Watters D. Cytostatic and cytotoxic properties of the marine product Bistratene A and analysis ofthe role ofPKC in its mode ofaction. Biochem Pharmacol 1993;45:1753-61.

Roivainen R, Messing RO. The phorbol derivatives thymeleatoxin and 12-deoxyphorbol-13-O-phenylacetate-20acetate cause translocation and down-regulation of multiple protein kinase C isozymes. FEBS Len 1993;319: 31-4.

Wilkinson SE, Parker PJ, Nixon JS. Isoenzyme specificity of bisindolylmaleimides, selective inhibition of protein kinase C. Biochem J 1993;294:335-7.

Cho YH, Ziboh VA. 13-hydroxyoctadecadienoic acid reverses epidermal hyperproliferation via selective inhibition of protein kinase C beta activity. Biochem Biophys Res Commun 1994;201:257-65.

Fearon ER, Vogelstein B. A genetic model of colorectal tumorigenesis. Cell 1990;61:759-67.

Lane DP. Cancer. p53, guardian of the genome. Nature 1994;358:15-16.

Vandenbark GR, Kuhn U, Niedel JE. Possible mechanism of phorbol diester-induced maturation of human promyelocytic leukemia cells. J Clin Invest 1984;73:448-57.

Yamauchi Y, Nagasawa K, Mayumi T, Horiuchi T, Niho Y Activation of protein kinase C induces differentiation in the human T-lymphoblastic cell line MOLT-3. Br J Cancer 1989;60:15-19.

Rozengurt E. Early signals in the mitogenic response. Science 1986;234: 161-6.

Berry N, Nishizuka Y Protein kinase C and T-cell activation. Eur Jf Biochem 1990;189:205-14.

Sanchez V, Lucas M, Sanz A, Gobema R. Decreased protein kinase C activity is associated with programmed cell death (apoptosis) in freshly isolated rat hepatocytes. Biosci Rep 1992;12: 199-206.

Moore NC, Jenkinson EJ, Owen JJT. Effects of the thymic microenvironment on the response of thymocytes to stimulation. Eur J Immunol 1992;22:2533-7.

Komada Y, Zhang XL, Zhou YW, Tanaka S, Higashiyama M, Ido M, et al. Apoptotic cell death induced by antiIgM antibody and phorbol esters is inhibited by IL4 in human B lymphoma cell line MBC-1. Cell Immunol 1994; 159:280-93.

Kiley S, Schaap D, Parker P, Hsieh L, Jaken S. Protein kinase C heterogeneity in GH4C rat pituitary cells. J Biol Chem 1990;265:15704-12.

Mischak H, Pierce JH, Goodnight J, Kazanietz MG, Blumberg PM, Muschinski JF. Phorbol ester-induced myeloid differentiation is mediated by protein kinase C-alpha and delta and not by beta 11, epsilon, zeta and eta. J Biol Chem 1993;268:20110-15.

Murray NR, Baumgardner GP, Burns DJ, Fields AP. Protein kinase C isotypes in human erythroleukemia (K562) cell proliferation and differentiation. Evidence that beta 11 protein kinase C is required for proliferation. J Biol Chem 1993;268: 15847-53.

Goss VL, Hocevar BA, Thompson LJ, Stratton CA, Bums DJ, Fields AP. Identification ofNuclear BII protein kinase C as a mitotic lamin linase. Biol Chem 1994;269:19074-80.

Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992;89:119-28.

MacFarlane DE, Manzel L. Activation of,-isozyme of protein kinase C (PKC 1) is necessary and sufficient for phorbol ester-induced differentiation of HL60 promyelocytes. J Biol Chem 1994;269:4327-3 1.

Knox KA, Johnson GD, Gordon J. A study ofprotein kinase C isoenzyme distribution in relation to Bcl-2 expression during apoptosis of epithelial cells in vivo. Exp Cell Res 1993;207:68-73.

Lazebnik YA, Cole S, Cooke CA, Nelson WG, Eamshaw WC. Nuclear events of apoptosis in vitro in cell-free mitotic extracts: a model system for analysis of the active phase of apoptosis. J CeU Biol 1993;123:7-22.

Pongracz J, Deacon EM, Lord JM. Activation versus apoptosis in neutrophils-differential involvement of PKC isoenzymes. J Cell Biochem 1995; in press.

Decock JBJ, Gillespie-Brown J, Parker PJ, Sugden PH, Fuller SJ. Classical, novel and atypical isoforms of PKC stimulate ANF and TRE/AP-1-regulated-promoter activity in ventricular cardiomyocytes. FEBS Len 1994;356: 275-8.